Focus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections

T. M. Jones, S. W. Johnson, V. P. DiMondi, D. T. Wilson

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalInfection and Drug Resistance
Volume9
DOIs
StatePublished - Jun 7 2016

Disciplines

  • Pharmacy and Pharmaceutical Sciences

Cite this